Pink Table Brunch attendees listening to remarks by Joseph J. Cappello, co-founder of Are You Dense, Inc, and Are You Dense Advocacy, Inc.at the FUJIFILM Wonder Photo Shop in New York.
Lexington, Mass., November 6, 2019 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, and part of the Fujifilm Healthcare portfolio, hosted a Pink Table Brunch on Tuesday, October 29, 2019 at the FUJIFILM Wonder Photo Shop to celebrate and honor breast cancer survivors, patients and their loved ones.
“As part of Fujifilm’s ‘Aspire to be Fearless’ nationwide mammography educational mobile coach tour, we are hosting various patient and clinician events to raise awareness about the importance of finding breast cancer early,” said Rick Banner, Senior Director, Marketing, FUJIFILM Medical Systems U.S.A., Inc. “At Fujifilm, we are committed to raising awareness through educational programs and are dedicated to promoting the early detection of breast cancer through advances in digital mammography.”
The Pink Table Brunch in New York was hosted with the goal of supporting the total wellbeing of survivors, patients and their loved ones — physically and emotionally. Special activities included professional headshots taken by Fujifilm photographers and networking opportunities.
The brunch also hosted keynote speaker Joseph J. Cappello, co-founder of Are You Dense, Inc, and Are You Dense Advocacy, Inc. Joe was elected to take on the leadership role as Executive Director of Are You Dense, Inc. and Are You Dense Advocacy, Inc. in January of 2019 after his wife, Nancy Capello’s passing from treatment related bone marrow cancer (MDS). His passion is to continue Nancy’s legacy by pursuing the goal that they set in 2004; that not one woman would die from a late stage breast cancer due to dense breast tissue. In 2009, Joe and Nancy championed the first in the nation breast density inform law in the State of Connecticut. In February 2019, their tireless efforts resulted in national legislation of breast density disclosure.
“We are pleased of the great strides that have been made in the early detection and treatment of breast cancer — and many women diagnosed with breast cancer are living long, healthy lives,” said Susan Crennan, Product Marketing Manager, Women’s Health, FUJIFILM Medical Systems U.S.A., Inc. “Progress in treatment and early detection has led to improved survival. Women whose breast cancer is detected at an early stage have on average a 90% survival rate in the first five years.”
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions that meet the evolving needs of healthcare facilities both today and tomorrow. From an unrivaled selection of digital X-ray systems (DR: detectors, mobiles, and rooms), to the comprehensive Synapse® Enterprise Imaging portfolio, to full-field digital mammography systems with digital breast tomosynthesis, and computed tomography solutions, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced endoscopic imaging solutions and devices to the medical field. Fujifilm’s TeraMedica Division, the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management and the core to the Synapse Enterprise Imaging portfolio, enables improved interoperability by connecting imaging content across the entire care continuum. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
The Pink Table Brunch is part of a series of educational events hosted by Fujifilm that will take place throughout the year in select markets around the country.